May 27, 2020

Contraceptive Drugs and Devices Market Is Projected to Grow at a Moderate CAGR during the Period 2020-2030

The Contraceptive Drugs and Devices Market - Global Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research & development activities, production and consumption, supply chain analysis, competitive landscape, and market composition analysis.

Contraceptive drugs and devices, also known as fertility and birth control products are used for protection against unwanted pregnancy and sexually transmitted diseases (STDs). These drugs and devices act as a barrier between the ovum and sperm by means of physical layers or drugs introduced into the body of male or female. The selection of contraceptive drug or device plays a vital role in safety of both male, and female. The hormonal contraceptives and intra uterine devices (IUDs) are highly effective at preventing pregnancy, however, does not prevent against sexually transmitted diseases (STDs). Thus, use of physical protection devices such as male or female latex condoms is recommended by health experts to prevent against unwanted pregnancy as well as infection from sexually transmitted diseases such as HIV, chlamydial infection, gonococcal infection, and trichomoniasis. As a result of these factors, the global contraceptive drugs and devices market is primarily dominated by contraceptive devices. The global contraceptive drugs and devices market is anticipated to grow at a CAGR of 6.5% during the forecast period.

Download free Sample Report- https://insightslice.com/request-sample/291

Fueled by dual advantages of prevention against STDs and unwanted pregnancy, the contraceptive devices to drive global market

The global contraceptive drugs and devices market is segmented based on product type, and geography. Based on product type, the global market is segmented into contraceptive drugs, and contraceptive devices. The contraceptive drugs are further sub-segmented into oral contraceptive pills, contraceptive injectable, and topical contraceptives. Similarly, the contraceptive devices are further sub-segmented into female contraceptive devices, and male contraceptive devices or male condoms. The female contraceptive devices are further sub-segmented into female condoms, diaphragms, sponges, intra uterine devices (IUD) (hormonal IUD, and copper IUD), sub-dermal contraceptive implants, and vaginal rings. Among the product types, contraceptive devices contributed largest share to the market in 2018 and is anticipated to grow at a prominent CAGR during forecast period. The contraceptive devices offer protection against STD, and unwanted pregnancy with an average failure rate less than 1.0% and does not pose any side effect on the user. The contraceptive drugs are anticipated to grow at a steady rate during forecast period owing to rising consumption of oral contraceptive pills.

Based on geography, the global contraceptive drugs and devices market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America dominated the market in 2018 owing high prevalence of contraceptive drugs and devices with an average contraceptive use rate of 75% across the continent. Moreover, high adoption of modern family planning methods is anticipated to fuel the growth of contraceptive drugs and devices market in North America in coming years. Asia Pacific is anticipated to be the fastest growing market during the forecast period owing to rising number of contraceptive drugs and users across the region. China is anticipated to be the largest market for contraceptive drugs and devices with an average 84% of the productive age population using some form of contraceptive drugs and devices.

Read More:- https://insightslice.com/report/Contraceptive-Drugs-and-Devices-Market/291

Major players dominating the global contraceptive drugs and devices market include Agile Therapeutics, ANI Pharmaceuticals, Inc., Bayer AG, Church & Dwight Co., Inc., Mayer Laboratories, Inc., Merck & Co., Inc., Pantarhei Bioscience, Pfizer Inc., Reckitt Benckiser Group plc, and Teva Pharmaceutical Industries Ltd.

About InsightSlice

insightSLICEis a market intelligenceand strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting with an aim to provide end-to-end solutions. For more details please contact our research and consulting team at info@insightslice.com.

Contact Us

Insight Slice

Email- Info@insightslice.com

Phone-+1 (707) 736-6633